Meritage Portfolio Management Moderna, Inc. Transaction History

Meritage Portfolio Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$96.41 - $126.61 $2,410 - $3,165	25 Added 1.29%	1,967 $203,000
Q2 2023 Jul 31, 2023	BUY	$118.5 - $160.53 $74,655 - $101,133	630 Added 48.02%	1,942 $236,000
Q1 2023 Apr 25, 2023	SELL	$135.66 - $197.02 $4,341 - $6,304	-32 Reduced 2.38%	1,312 $201,000
Q4 2022 Feb 01, 2023	BUY	$118.38 - $210.04 $159,102 - $282,293	1,344 New	1,344 $241,000
Q1 2022 Apr 25, 2022	SELL	$126.46 - $235.05 $4.51 Million - $8.38 Million	-35,670 Reduced 95.77%	1,576 $271,000
Q4 2021 Jan 28, 2022	BUY	$225.82 - $368.51 $8.16 Million - $13.3 Million	36,123 Added 3216.65%	37,246 $9.46 Million
Q3 2021 Oct 26, 2021	SELL	$221.9 - $484.47 $5,103 - $11,142	-23 Reduced 2.01%	1,123 $432,000
Q2 2021 Jul 26, 2021	SELL	$129.91 - $234.98 $57,550 - $104,096	-443 Reduced 27.88%	1,146 $269,000
Q1 2021 Apr 27, 2021	SELL	$109.18 - $185.98 $367,390 - $625,822	-3,365 Reduced 67.92%	1,589 $208,000
Q4 2020 Feb 03, 2021	BUY	$65.74 - $169.86 $325,675 - $841,486	4,954 New	4,954 $518,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

Stay updated on Meritage Portfolio Management with notifications on news.